Relationship Between Self-Report and Clinician-Rated Impairment in Depressed Outpatients

Kramer, Teresa L.; Owen, Richard R.; Wilson, Crystal; Thrush, Carol R.
August 2003
Community Mental Health Journal;Aug2003, Vol. 39 Issue 4, p299
Academic Journal
This study examined the potential of using the Global Assessment of Functioning (GAF) scale as a valid measure of patient-reported status and predictor of three-month outcomes for 59 patients seeking outpatient treatment for depression. A moderate relationship between the GAF and patient report at baseline and follow-up suggests it may be clinically useful for routine monitoring of depressed patients.


Related Articles

  • Effective Treatment for Depression: St. John's Wort.  // Annals of the American Psychotherapy Association;Winter2008, Vol. 11 Issue 4, p7 

    The article presents information on a study which examined the therapeutic use of St. John's wort for treating mental depression. Participants of the study were asked to rate the severity of their depression after taking various treatments, using the Hamilton Rating Scale for Depression. The...

  • Common Treatment of Polycystic Ovarian Syndrome and Major Depressive Disorder: Case Report and Review. Rasgon, N.L.; Carter, M.S.; Elman, S.; Bauer, M.; Love, M.; Korenman, S.G. // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Apr2002, Vol. 2 Issue 1, p97 

    We present the case of a young woman with treatment-resistant major depression, who presented to the Mood Disorders Clinic with a Hamilton Psychiatric Rating Scale for Depression (HAM-D-21) score of 28, after a year-long treatment with Effexor-XR. The patient also had untreated Polycystic...

  • An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder. Hooper, Cynthia L.; Bakish, David // Journal of Psychiatry & Neuroscience;Mar2000, Vol. 25 Issue 2, p178 

    Examines sensitivity of the 6-item Hamilton Rating Scale for Depression (HRSD6) in patients suffering from major depressive disorder. Comparison of HRSD6 with the 17-item HRSD and Montgomery-Asberg Depression Rating Scale; Analysis of four antidepressant treatments; Need for a shorter and less...

  • The Major Depression Inventory versus Schedules for Clinical Assessment in Neuropsychiatry in a population sample. Forsell, Yvonne // Social Psychiatry & Psychiatric Epidemiology;Mar2005, Vol. 40 Issue 3, p209 

    Aims: This study examined the association between the Major Depression Inventory (MDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN).Methodology: A questionnaire including the MDI was sent out to an adult population and was completed by a total of...

  • Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: The Nord-Trøndelag Health Study (HUNT). Bækken, Petter M.; Skorpen, Frank; Stordal, Eystein; Zwart, John-Anker; Hagen, Knut // BMC Psychiatry;2008, Vol. 8, Special section p1 

    Background: The catechol-O-methyltransferase (COMT) gene contains a functional polymorphism, Val158Met, which has been linked to anxiety and depression, but previous results are not conclusive. The aim of the present study was to examine the relationship between the Val158Met COMT gene...

  • Changes in mood, appetite and psychomotor retardation in depressed patients given ECT. Browning, S. M.; Cowen, P. J. // British Journal of Psychiatry;Sep86, Vol. 149, p371 

    The article presents a study which used the Montgomery-Äsberg depression scale (MADS) to investigate the changes in severity of a variety of depressive symptoms over time. The study suggested that the MADS might be an appropriate instrument with which to investigate the clinical impressions...

  • Understanding the Transience or Persistence of Depression. Westermeyer, Joseph // American Journal of Public Health;Sep82, Vol. 72 Issue 9, p982 

    The article discusses research being done on depression. A brief history on research into depression is given. It presents information on a number of clinical rating scales that are used for quantifying depressive symptoms. It also cites instruments for studying depression that are gradually...

  • Depression--the hidden symptom in advanced cancer. Lloyd-Williams, Mari // Journal of the Royal Society of Medicine;Dec2003, Vol. 96 Issue 12, p577 

    The article discusses the role of screening tools on the treatment of depression, which is said to be a symptom in advanced cancer. Because patients are not eager to describe their depressive symptoms, staff need to know how to recognize depression. One method of assessing depression is through...

  • Abortion Pill Could Fight Psychotic Depression.  // Journal of Psychosocial Nursing & Mental Health Services;Aug2005, Vol. 43 Issue 8, p14 

    The article reports on the outcome of a trial of the abortifacient mifepristone for the treatment of psychotic depression, conducted by researchers from the Keck School of Medicine at the University of Southern California. The patients were evaluated using the Hamilton Rating Scale for...


Read the Article

Other Topics